I think there are some actions the company will have to take and some expenses the company will have to incur that will make it tough. I still think given those parameters, it can be, stay and remain an independent company and eventually flourish. - Jan Wald Quotes
I think there are some actions the company will have to take and some expenses the company will have to incur that will make it tough. I still think given those parameters, it can be, stay and remain an independent company and eventually flourish. Jan Wald
 

More - Jan Wald Quotes

I don't think there's much risk to employees ? especially the Minnesota contingent. - Jan Wald Quotes

I don't think there's much risk to employees ? especially the Minnesota contingent.

Jan Wald

 
What the FDA seemed to be saying is that it doesn't know if Boston Scientific has a systemic, corporate-wide quality policy, and until it does the FDA will not permit the company to gain product approvals in adulterated plants. - Jan Wald Quotes

What the FDA seemed to be saying is that it doesn't know if Boston Scientific has a systemic, corporate-wide quality policy, and until it does the FDA will not permit the company to gain product approvals in adulterated plants.

Jan Wald

 Boston
After all the noise they made, there would certainly be a lot of questions asked (if they raised their bid). - Jan Wald Quotes

After all the noise they made, there would certainly be a lot of questions asked (if they raised their bid).

Jan Wald

 
Boston Scientific will do everything in its power to reach a deal with Guidant. - Jan Wald Quotes

Boston Scientific will do everything in its power to reach a deal with Guidant.

Jan Wald

 Boston
In investors' minds, they've been accused of being a one-trick pony, and they don't have a pipeline. If they get Guidant, they answer both those questions. They'll be in one of the fastest-growing medical devices markets, for implantable defibrillators, and they'll have Guidant's pipeline. - Jan Wald Quotes

In investors' minds, they've been accused of being a one-trick pony, and they don't have a pipeline. If they get Guidant, they answer both those questions. They'll be in one of the fastest-growing medical devices markets, for implantable defibrillators, and they'll have Guidant's pipeline.

Jan Wald

 
J&J needs something like Guidant to revitalize its growth. People are now thinking that if J&J does walk away, St. Jude is in their scopes. - Jan Wald Quotes

J&J needs something like Guidant to revitalize its growth. People are now thinking that if J&J does walk away, St. Jude is in their scopes.

Jan Wald

 Growth
People are Guidant's most important asset, ... so there are hard trade-offs for Guidant to work through. - Jan Wald Quotes

People are Guidant's most important asset, ... so there are hard trade-offs for Guidant to work through.

Jan Wald

 People
We think that most investors do not appreciate how far along BSX might be in rectifying this problem in a timely manner, because a fix was in process at the time of the [FDA] inspections. - Jan Wald Quotes

We think that most investors do not appreciate how far along BSX might be in rectifying this problem in a timely manner, because a fix was in process at the time of the [FDA] inspections.

Jan Wald

 
They might have passed the acid test of being too big. - Jan Wald Quotes

They might have passed the acid test of being too big.

Jan Wald

 
One thing the company loses by not being part of J&J is not having more money for market development education and training - Jan Wald Quotes

One thing the company loses by not being part of J&J is not having more money for market development education and training

Jan Wald

 
Click To See More Quotes

Quotes By Popular Topics
Best Friends
Birthday
Change
Education
Family
Friends
Funny
Happiness
Hard Work
inspirational
Leadership
Life
Lifestyle
Lost Love
Love
Motivational
Positive
Smile
Smiles
Success
Work
View All Topics (A - Z)
Like Our Facebook Page
Motivational, Inspirational, Funny Quotes